The Star Hepto-Protector

COMPOSITION: L-Ornithine, L-Aspartate 150 mg



  • LOLA is an effective ammonia-lowering agent currently employed for the treatment of hepatic encephalopathy (HE).
  • It stimulates both urea synthesis by residual hepatocytes and muscle glutamine synthesis together with putative hepatoprotective actions. 
  • Treatment of cirrhotic patients with LOLA limits ammonia-induced sarcopenia by improving muscle protein synthesis and function. 
  • It is conceivable that the antisarcopenic action of LOLA contributes to its efficacy for the treatment of HE in cirrhosis.